|
C反应蛋白–白蛋白–淋巴细胞(CALLY)指数对皮肌炎患者间质性肺病和疾病活动度的预测价值
|
Abstract:
背景:C反应蛋白–白蛋白–淋巴细胞(CALLY)指数在具有免疫过程的疾病中显示出良好的前景。然而,有关其在皮肌炎中的应用的研究还很有限。这项回顾性研究旨在评估CALLY对皮肌炎患者的间质性肺病和疾病活动度的预测价值。方法:我们收集了105位皮肌炎患者(45位患有间质性肺炎,60位无间质性肺炎)和102名健康对照者的临床数据。从电子医疗记录中提取临床特征,采用二元逻辑回归和ROC曲线分析CALLY、临床特征和疾病活动度之间的相关性。结果:皮肌炎患者的CALLY水平明显低于对照组(P < 0.001)。在皮肌炎组中,间质性肺炎患者的CALLY水平明显低于非间质性肺炎患者(P < 0.05)。CALLY与VAS总分呈负相关(r = ?0.305, P = 0.002)。ROC分析确定预测皮肌炎患者无ILD的最佳CALLY临界值为8.41 (敏感性91.1%,特异性40%,曲线下面积 = 0.620)。Logistic回归分析确定CALLY (p = 0.005)是无间质性肺炎的皮肌炎的独立预测指标。结论:CALLY与DM患者的不合并间质性肺炎和疾病活动度降低有明显相关性,这表明它在DM的评估和监测方面具有一定潜力。
Background: The C-reactive protein-albumin-lymphocyte (CALLY) index has demonstrated potential in assessing diseases with immunological processes. However, investigations into its applicability in dermatomyositis (DM) remain limited. This retrospective study aims to assess the predictive value of the CALLY index for interstitial lung disease and disease activity in patients with dermatomyositis. Methods: Data from 105 patients with DM (45 with interstitial lung disease [ILD], 60 without ILD) and 102 healthy controls were collected. Relevant clinical characteristics were extracted from medical records. Logistic regression and receiver operating characteristic (ROC) curve analyses were employed to examine correlations among CALLY, clinical characteristics, and disease activity. Results: Patients with DM demonstrated significantly lower CALLY values compared to controls (P < 0.001). Within the DM cohort, patients with ILD exhibited significantly lower CALLY values than those without ILD (P <0.05). CALLY showed a negative correlation with the global Visual Analogue Scale (VAS) score (r = ?0.305, P = 0.002). ROC analysis determined the optimal CALLY cutoff value for predicting non-ILD in DM patients to be 8.41 (sensitivity 91.1%, specificity 40%, area under the ROC curve = 0.620). CALLY (P = 0.005) was identified as an independent predictor of DM without concurrent ILD. Conclusions: The CALLY index demonstrated a significant association with the absence of interstitial lung disease and reduced disease activity in patients with DM, indicating its potential utility in the assessment and monitoring of dermatomyositis.
[1] | Yang, S., Chang, C. and Lian, Z. (2019) Polymyositis and Dermatomyositis—Challenges in Diagnosis and Management. Journal of Translational Autoimmunity, 2, Article ID: 100018. https://doi.org/10.1016/j.jtauto.2019.100018 |
[2] | Griger, Z., Nagy-Vincze, M. and Dankó, K. (2017) Pharmacological Management of Dermatomyositis. Expert Review of Clinical Pharmacology, 10, 1109-1118. https://doi.org/10.1080/17512433.2017.1353910 |
[3] | Lu, X., Peng, Q. and Wang, G. (2022) Biomarkers of Disease Activity in Dermatomyositis. Current Opinion in Rheumatology, 34, 289-294. https://doi.org/10.1097/bor.0000000000000905 |
[4] | Shahrabi, S., Saki, N., Safa, M. and Pezeshki, S. (2023) Complete Blood Count Test in Rheumatology: Not Just a Screening Test. Clinical Laboratory, 69, 1-4. https://doi.org/10.7754/clin.lab.2022.221012 |
[5] | Ma, R., Okugawa, Y., Shimura, T., Yamashita, S., Sato, Y., Yin, C., et al. (2024) Clinical Implications of C-Reactive Protein-Albumin-Lymphocyte (CALLY) Index in Patients with Esophageal Cancer. Surgical Oncology, 53, Article ID: 102044. https://doi.org/10.1016/j.suronc.2024.102044 |
[6] | Schett, G., McInnes, I.B. and Neurath, M.F. (2021) Reframing Immune-Mediated Inflammatory Diseases through Signature Cytokine Hubs. New England Journal of Medicine, 385, 628-639. https://doi.org/10.1056/nejmra1909094 |
[7] | Lundberg, I.E., Tjärnlund, A., Bottai, M., Werth, V.P., Pilkington, C., Visser, M.d., et al. (2017) 2017 European League against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups. Annals of the Rheumatic Diseases, 76, 1955-1964. https://doi.org/10.1136/annrheumdis-2017-211468 |
[8] | Travis, W.D., Costabel, U., Hansell, D.M., King, T.E., Lynch, D.A., Nicholson, A.G., et al. (2013) An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias. American Journal of Respiratory and Critical Care Medicine, 188, 733-748. https://doi.org/10.1164/rccm.201308-1483st |
[9] | Isenberg, D.A., Allen, E., Farewell, V., Ehrenstein, M.R., Hanna, M.G., Lundberg, I.E., et al. (2003) International Consensus Outcome Measures for Patients with Idiopathic Inflammatory Myopathies. Development and Initial Validation of Myositis Activity and Damage Indices in Patients with Adult Onset Disease. Rheumatology, 43, 49-54. https://doi.org/10.1093/rheumatology/keg427 |
[10] | Dalakas, M.C. (2004) Inflammatory Disorders of Muscle: Progress in Polymyositis, Dermatomyositis and Inclusion Body Myositis. Current Opinion in Neurology, 17, 561-567. https://doi.org/10.1097/00019052-200410000-00006 |
[11] | Gunawardena, H., Betteridge, Z.E. and McHugh, N.J. (2009) Myositis-Specific Autoantibodies: Their Clinical and Pathogenic Significance in Disease Expression. Rheumatology, 48, 607-612. https://doi.org/10.1093/rheumatology/kep078 |
[12] | Selva-O’Callaghan, A., Pinal-Fernandez, I., Trallero-Araguás, E., Milisenda, J.C., Grau-Junyent, J.M. and Mammen, A.L. (2018) Classification and Management of Adult Inflammatory Myopathies. The Lancet Neurology, 17, 816-828. https://doi.org/10.1016/s1474-4422(18)30254-0 |
[13] | Eckart, A., Struja, T., Kutz, A., Baumgartner, A., Baumgartner, T., Zurfluh, S., et al. (2020) Relationship of Nutritional Status, Inflammation, and Serum Albumin Levels during Acute Illness: A Prospective Study. The American Journal of Medicine, 133, 713-722.e7. https://doi.org/10.1016/j.amjmed.2019.10.031 |
[14] | Huang, L., Li, X., Zhou, W., Zhu, H., Lao, Y., Huang, X., et al. (2024) The Clinical Value of the Neutrophil-to-Lymphocyte Ratio, the C-Reactive Protein-to-Albumin Ratio, the Systemic Inflammatory Index, and the Systemic Inflammatory Response Index in Patients with the Anti-Synthetase Syndrome. Journal of Inflammation Research, 17, 3617-3628. https://doi.org/10.2147/jir.s460610 |
[15] | Yao, Z., Zhang, Y. and Wu, H. (2019) Regulation of C-Reactive Protein Conformation in Inflammation. Inflammation Research, 68, 815-823. https://doi.org/10.1007/s00011-019-01269-1 |
[16] | Yang, W., Wang, X., Zhang, W., Ying, H., Xu, Y., Zhang, J., et al. (2017) Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio Are 2 New Inflammatory Markers Associated with Pulmonary Involvement and Disease Activity in Patients with Dermatomyositis. Clinica Chimica Acta, 465, 11-16. https://doi.org/10.1016/j.cca.2016.12.007 |
[17] | Wang, D.X., Lu, X., Zu, N., Lin, B., Wang, L.Y., Shu, X.M., et al. (2012) Clinical Significance of Peripheral Blood Lymphocyte Subsets in Patients with Polymyositis and Dermatomyositis. Clinical Rheumatology, 31, 1691-1697. https://doi.org/10.1007/s10067-012-2075-4 |
[18] | Khojah, A., Pachman, L.M., Bukhari, A., Trinh, C., Morgan, G., Pandey, S., et al. (2024) Decreased Peripheral Blood Natural Killer Cell Count in Untreated Juvenile Dermatomyositis Is Associated with Muscle Weakness. International Journal of Molecular Sciences, 25, Article No. 7126. https://doi.org/10.3390/ijms25137126 |
[19] | Yang, M., Lin, S., Liu, X., Tang, M., Hu, C., Wang, Z., et al. (2023) Association between C-Reactive Protein-Albumin-Lymphocyte (CALLY) Index and Overall Survival in Patients with Colorectal Cancer: From the Investigation on Nutrition Status and Clinical Outcome of Common Cancers Study. Frontiers in Immunology, 14, Article ID: 1131496. https://doi.org/10.3389/fimmu.2023.1131496 |
[20] | Zhang, H., Shi, J., Xie, H., Liu, X., Ruan, G., Lin, S., et al. (2023) Superiority of CRP-Albumin-Lymphocyte Index as a Prognostic Biomarker for Patients with Gastric Cancer. Nutrition, 116, Article ID: 112191. https://doi.org/10.1016/j.nut.2023.112191 |
[21] | Iida, H., Tani, M., Komeda, K., Nomi, T., Matsushima, H., Tanaka, S., et al. (2022) Superiority of CRP-Albumin-Lymphocyte Index (CALLY Index) as a Non-Invasive Prognostic Biomarker after Hepatectomy for Hepatocellular Carcinoma. HPB, 24, 101-115. https://doi.org/10.1016/j.hpb.2021.06.414 |
[22] | Feng, J., Wang, L., Yang, X. and Chen, Q. (2024) Clinical Significance of Preoperative CALLY Index for Prognostication in Patients with Esophageal Squamous Cell Carcinoma Undergoing Surgery. Scientific Reports, 14, Article No. 713. https://doi.org/10.1038/s41598-023-51109-w |
[23] | Tsai, Y., Ko, C., Chen, H., Hsu, C., Lai, C., Lee, Y., et al. (2022) Prognostic Value of CRP-Albumin-Lymphocyte (CALLY) Index in Patients Undergoing Surgery for Oral Cavity Cancer. Journal of Cancer, 13, 3000-3012. https://doi.org/10.7150/jca.74930 |
[24] | Xu, Z., Tang, J., Chen, X., Jin, Y., Zhang, H. and Liang, R. (2024) Associations of C-Reactive Protein-Albumin-Lymphocyte (CALLY) Index with Cardiorenal Syndrome: Insights from a Population-Based Study. Heliyon, 10, e37197. https://doi.org/10.1016/j.heliyon.2024.e37197 |
[25] | Li, Y., Wei, Q., Ke, X., Xu, Y., Xu, B., Zhang, K., et al. (2024) Higher CALLY Index Levels Indicate Lower Sarcopenia Risk among Middle-Aged and Elderly Community Residents as Well as Hospitalized Patients. Scientific Reports, 14, Article No. 24591. https://doi.org/10.1038/s41598-024-75164-z |
[26] | Marie, I. (2012) Morbidity and Mortality in Adult Polymyositis and Dermatomyositis. Current Rheumatology Reports, 14, 275-285. https://doi.org/10.1007/s11926-012-0249-3 |
[27] | Olazagasti, J.M., Niewold, T.B. and Reed, A.M. (2015) Immunological Biomarkers in Dermatomyositis. Current Rheumatology Reports, 17, Article No. 68. https://doi.org/10.1007/s11926-015-0543-y |
[28] | Ha, Y., Hur, J., Go, D.J., Kang, E.H., Park, J.K., Lee, E.Y., et al. (2018) Baseline Peripheral Blood Neutrophil-to-Lymphocyte Ratio Could Predict Survival in Patients with Adult Polymyositis and Dermatomyositis: A Retrospective Observational Study. PLOS ONE, 13, e0190411. https://doi.org/10.1371/journal.pone.0190411 |
[29] | Gao, M., Huang, Y., Wu, X., Xu, Q., Ji, R., Gu, B., et al. (2017) Red Blood Cell Distribution Width and Neutrophil to Lymphocyte Ratio Are Correlated with Disease Activity of Dermatomyositis and Polymyositis. Journal of Clinical Laboratory Analysis, 32, e22209. https://doi.org/10.1002/jcla.22209 |
[30] | Nicoletis, I., Pasco, J., Maillot, F., Goupille, P., Corcia, P., Grammatico-Guillon, L., et al. (2020) High Pre-Treatment Neutrophil-to-Lymphocyte Ratio in Patients with Dermatomyositis/Polymyositis Predicts an Increased Risk of Cancer. European Journal of Dermatology, 30, 133-139. https://doi.org/10.1684/ejd.2020.3756 |